Citation Impact
Citing Papers
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Cancer treatment and survivorship statistics, 2022
2022 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Lung allograft rejection: diagnosis and management
2009
Macrophages in immunoregulation and therapeutics
2023 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction
2017
Macrophages and cancer
2008
Pediatric Lung Transplantation
2010
Gold nanorods and their plasmonic properties
2012 Standout
Nanopharmaceuticals (part 1): products on the market
2014
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
Protective and pathogenic functions of macrophage subsets
2011 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
2021
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Moving forward in plant food safety and security through NanoBioSensors: Adopt or adapt biomedical technologies?
2015
Macrophages and the hypoxic tumour microenvironment
2007
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
2015
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Effect of CTAB coating on structural, magnetic and peroxidase mimic activity of ferric oxide nanoparticles
2018
Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges
2021 Standout
Works of Peter Eu being referenced
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
2018
Alemtuzumab in the Treatment of Refractory Acute Rejection and Bronchiolitis Obliterans Syndrome After Human Lung Transplantation
2007
Quasi-Cubic Magnetite/Silica Core-Shell Nanoparticles as Enhanced MRI Contrast Agents for Cancer Imaging
2011
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
2006
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
2010
Development and use of iron oxide nanoparticles (Part 2): The application of iron oxide contrast agents in MRI
2010